Lamellar Biomedical Limited
https://www.lamellar.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Lamellar Biomedical Limited
Motif Plunges As FDA Demands New Iclaprim Study
The UK biotech is in dire need of further funding after US regulators requested an additional clinical trial for its much-delayed skin infection antibiotic.
Company Information
- Industry
- Biotechnology
- Medical Devices
-
Pharmaceuticals
- Drug Delivery
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice